Beyond GLP-1s: How device therapy could mitigate the obesity epidemic
This episode explores device therapy's role in the obesity epidemic, focusing on GLP-1s and market developments. Fractyl Health CEO Harith Rajagopalan discusses the company's prospects, GLP-1 advancements, and marketing impacts. The episode also covers Eli Lilly's market…